Literature DB >> 619935

Monitoring digoxin therapy: III. How useful are the nomograms?

J K Aronson.   

Abstract

1. A previously described set of guidelines for digoxin therapy has been evaluated in twenty-four patients. 2. Six different published methods (nomograms and equations) for predicting digoxin requirements have been studied to determine their clinical usefulness in the context of the twenty-four patients. 3. The limitations of the nomograms and equations are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 619935      PMCID: PMC1429222          DOI: 10.1111/j.1365-2125.1978.tb01598.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  Digoxin pharmacokinetics: role of renal failure in dosage regimen design.

Authors:  J R Koup; W J Jusko; C M Elwood; R K Kohli
Journal:  Clin Pharmacol Ther       Date:  1975-07       Impact factor: 6.875

Review 2.  A nomogram for digoxin therapy.

Authors:  R W Jelliffe; G Brooker
Journal:  Am J Med       Date:  1974-07       Impact factor: 4.965

3.  Rapid evaluation of creatinine clearance.

Authors:  K Siersbaek-Nielsen; J M Hansen; J Kampmann; M Kristensen
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

4.  A pharmacokinetic slide rule for more accurate drug treatment.

Authors:  P Bättig; K Brune; H Schmitt; D Walz
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

5.  Modelling of individual pharmacokinetics for computer-aided drug dosage.

Authors:  L B Sheiner; B Rosenberg; K L Melmon
Journal:  Comput Biomed Res       Date:  1972-10

6.  Serum-phenytoin levels in management of epilepsy.

Authors:  A Richens; A Dunlop
Journal:  Lancet       Date:  1975-08-09       Impact factor: 79.321

7.  Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  D W Duhme; D J Greenblatt; J Koch-Weser
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

8.  Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.

Authors:  D J Sumner; A J Russell
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

9.  Can digoxin dose requirements be predicted?

Authors:  S M Dobbs; G E Mawer; M Rodgers; B G Woodcock; S B Lucas
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

10.  Digoxin metabolism in hypo- and hyperthyroidism. Studies with tritiated digoxin in thyroid disease.

Authors:  J E Doherty; W H Perkins
Journal:  Ann Intern Med       Date:  1966-03       Impact factor: 25.391

View more
  8 in total

Review 1.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

2.  Digoxin dose precision: prescribing aids or intuition?

Authors:  G D Johnston
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

3.  Evaluation of two prediction models for digoxin dosing.

Authors:  S L Markantonis; A Kyroudis; T Christopoulos
Journal:  Pharm World Sci       Date:  1993-02-19

Review 4.  Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

Review 5.  Indications for the measurement of plasma digoxin concentrations.

Authors:  J K Aronson
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of digoxin 1980.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

7.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

8.  A simple aid to digoxin prescribing.

Authors:  A J Taggart; D G McDevitt; G D Johnston
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.